Patents Assigned to Appili Therapeutics Inc.
  • ORAL FORMULATIONS OF METRONIDAZOLE AND METHODS OF TREATING AN INFECTION USING SAME
    Publication number: 20230086660
    Abstract: The present disclosure provides oral pharmaceutical compositions comprising: 1) metronidazole or a pharmaceutically acceptable salt thereof; and magnesium aluminum silicate; or 2) metronidazole or a pharmaceutically acceptable salt thereof; magnesium aluminum silicate; and a flavoring agent. Methods of treating infection utilizing the oral pharmaceutical compositions are also provided.
    Type: Application
    Filed: November 30, 2022
    Publication date: March 23, 2023
    Applicant: Appili Therapeutics Inc.
    Inventors: Bernard J. Guarino, JR., Jamie L. Doran, Zorana Radovic, Kevin Sullivan
  • Oral formulations of metronidazole and methods of treating an infection using same
    Patent number: 11541035
    Abstract: The present disclosure provides oral pharmaceutical compositions comprising: 1) metronidazole or a pharmaceutically acceptable salt thereof; and magnesium aluminum silicate; or 2) metronidazole or a pharmaceutically acceptable salt thereof; magnesium aluminum silicate; and a flavoring agent. Methods of treating infection utilizing the oral pharmaceutical compositions are also provided.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: January 3, 2023
    Assignee: Appili Therapeutics Inc.
    Inventors: Bernard J. Guarino, Jr., Jamie L. Doran, Zorana Radovic, Kevin Sullivan
  • COMPOSITION AND METHOD FOR TREATING CANDIDA AURIS INFECTION
    Publication number: 20220257578
    Abstract: Candida auris infection in a subject is treated with 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy}benzamidine (T-2307) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 3, 2022
    Publication date: August 18, 2022
    Applicant: Appili Therapeutics Inc.
    Inventors: Thomas F. PATTERSON, Nathan P. WIEDERHOLD, Laura K. NAJVAR
  • ORAL FORMULATIONS OF METRONIDAZOLE AND METHODS OF TREATING AN INFECTION USING SAME
    Publication number: 20210069153
    Abstract: The present disclosure provides oral pharmaceutical compositions comprising: 1) metronidazole or a pharmaceutically acceptable salt thereof; and magnesium aluminum silicate; or 2) metronidazole or a pharmaceutically acceptable salt thereof; magnesium aluminum silicate; and a flavoring agent. Methods of treating infection utilizing the oral pharmaceutical compositions are also provided.
    Type: Application
    Filed: January 16, 2019
    Publication date: March 11, 2021
    Applicant: Appili Therapeutics Inc.
    Inventors: Bernard J. Guarino, Jr., Jamie L. Doran, Zorana Radovic, Kevin Sullivan